Nanjing, China

Meiling Mo

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nanjing Heron Pharmaceutical Science and Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meiling Mo. Retrieved from https://idiyas.com/inventor/meiling-mo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meiling Mo - Innovator in Pharmaceutical Science

Introduction

Meiling Mo is a prominent inventor based in Nanjing, China. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. Her work focuses on improving the efficacy and safety of medications, which is crucial for patient care.

Latest Patents

Meiling Mo holds 1 patent for her invention titled "Ketorolaco derivative, pharmaceutical composition and preparation method therefor and use thereof." This patent describes a ketorolaco derivative that exhibits a better half-life and stability, along with improved pharmacokinetic properties. The invention addresses common issues associated with traditional ketorolaco preparations, such as frequent administration, gastrointestinal side effects, and poor patient compliance.

Career Highlights

Meiling Mo is affiliated with Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. Her role in the company allows her to apply her innovative ideas in a practical setting, contributing to the advancement of pharmaceutical technologies. Her dedication to research and development has positioned her as a key player in her field.

Collaborations

Meiling has collaborated with notable colleagues, including Hai Ye and Tao Min. These partnerships enhance her research efforts and foster a collaborative environment for innovation.

Conclusion

Meiling Mo's contributions to pharmaceutical science exemplify the impact of innovation in healthcare. Her work not only improves drug formulations but also enhances patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…